Sarcopenia-3D-Scan
Sarcopenia, age related decrease in muscle mass, strength and function afflicts 10.4 million older adults. Declining physical function is a hallmark of sarcopenic obesity. Early screening can help intervene to improve functional outcomes and reduce the risk of severe health outcomes. Current methods of assessing muscle, fat, and bone quantity (body composition) and physical function are not practical in the clinical setting.
This study uses optical scans to determine 3D body surface shapes, DEXA scan to determine body composition, and a series of physical tests to measure overall function. This data will be used to train and validate AI systems to predict body composition and physical function using commonly available mobile devices (e.g. phone or tablet).
Why is this study being done?
- We hope to use the study to develop an inexpensive, noninvasive, and accurate method to assess loss of muscle mass, strength, and function that can be done using commonly available mobile devices (e.g. phone or tablet).
Who can participate?
- Adults > 65 years of age.
- No previous history of cosmetic or body contour-altering surgery.
- No condition that alters body shape or contour.
- Weight < 450 lbs. / BMI< 60kg/m2
- Be able to walk 20 feet independently
Why should I participate?
- You will be helping other adults with or at risk of sarcopenic obesity.
- You will be compensated $150/study person (travel included).
- Any information you provide in this study including the 3D optical scan will be kept strictly confidential and will not be shared.
What will happen during this study?
- This study consists of a 3D optical scanning session, a DEXA scanning session, a physical function evaluation, and self-reported questionnaires.
How can I learn more about the study?
- If you are interested in the study, please let your doctor or the study team know you are interested in learning more about the study.
Contact our study team:
Dr. Rachel Wilcox
Phone: 202-994-3699
Email: OIMStudy
gwu [dot] edu